Dear Client: The US Drug Enforcement Administration (DEA) is set to reclassify cannabis from a Schedule I to a Schedule III drug, according to people familiar with the matter, reports The Associated Press. HOW WE GOT HERE. The rescheduling process kicked off in the fall of 2022, when the Biden Administration announced a multi-pronged plan to change the way the federal government handles cannabis, which included a request to the Secretary of Health and Human Services (HHS) and the Attorney
You need a subscription to access this article.Login now or subscribe to get daily industry insights!
Log In
Forgot Password
Don’t have an account yet?
SUBSCRIBE